Classification of Encapsulating Peritoneal Sclerosis is Important,but Must Encapsulate the Entire Spectrum of the Disease

Gandhi V.C. , Humayun H.M. , Ing T.S. , Daugirdas J.T. , Jablokow V.R. , Iwatsuki S. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140: 1201–3.

Bradley J.A. , Hamilton D.N. , McWhinnie D.L. , Briggs J.D. , Junor B.J. Sclerosing peritonitis after CAPD. Lancet 1983; 2: 572–3.

Brown P. , Baddeley H. , Read A.E. , Davies J.D. , McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet 1974; 2: 1477–81.

Eltringham W.K. , Espiner H.J. , Windsor C.W. , Griffiths D.A. , Davies J.D. , Baddeley H. Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management. BR J Surg 1977; 64: 229–35.

Jackson B.T. Surgical treatment of sclerosing peritonitis caused by practolol. BR J Surg 1977; 64: 255–7.

Latus J. , Ulmer C. , Fritz P. , Rettenmaier B. , Biegger D. , Lang T. Phenotypes of encapsulating peritoneal sclerosis—macroscopic appearance, histologic findings, and outcome. Perit Dial Int 2013; 33: 495–502.

Habib S.M. , Hagen S.M. , Korte M.R. , Zietse R. , Dor F.J. , Betjes M.G. Localized encapsulating peritoneal sclerosis constricting the terminal ileum—an unusual appearance requiring surgical intervention. Perit Dial Int 2013; 33: 503–506.

Sugarbaker P.H. , Kern K. , Lack E. Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. Dis Colon rectum 1987; 30: 772–9.

Ulmer C. , Braun N. , Rieber F. , Latus J. , Hirschburger S. , Emmel J. Efficacy and morbidity of surgical therapy in late-stage encapsulating peritoneal sclerosis. surgery 2013; 153: 219–24.

Kawanishi H. , Shintaku S. , Moriishi M. , Dohi K. , Tsuchiya S. Seventeen years’ experience of surgical options for encapsulating peritoneal sclerosis. Adv Perit Dial 2011; 27: 53–8.

Kawanishi H. , Watanabe H. , Moriishi M. , Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4): S39–47.

Allaria P.M. , Giangrande A. , Gandini E. , Pisoni I.B. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999; 12: 395–7.

Guest S. Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences. Perit Dial Int 2009; 29: 252–5.

Korte M.R. , Fieren M.W. , Sampimon D.E. , Lingsma H.F. , Weimar W. , Betjes MG on behalf of the investigators of the Dutch Multicentre EPS Study. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial transplant 2011; 26: 691–7.